Natural Health Trends Corp. Financial Ratios — NHTC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	105.12	125.62	113.48	79.12	27.25	34.39	-6.8	1.18	1.71	0.57	1.24	1.54	-3.13
Return on Assets (%)	40.14	36.68	29.16	56.3	53.47	40.47	15.33	19.55	-4.06	0.75	1.06	0.35	0.75	0.92	-1.88
Return on Capital (%)	- -	- -	102.4	125.25	113.48	79.12	27.25	34.39	- -	1.12	1.62	0.54	1.14	1.42	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	73.78	74.18	76.11	78.34	79.57	80.92	80.44	79.49	74.1	72.63	74.99	74.23	74.56	73.98	73.54
EBITDA Margin (%)	6.68	7.17	8.17	16.8	18.18	22.43	22.07	17.8	-6.28	1.74	3.12	-0.13	-3.43	-2.72	-4.27
Operating Margin (%)	5.72	7.05	8.04	16.71	18.08	22.29	21.8	17.58	-6.78	1.08	2.62	-0.55	-3.8	-3.02	-4.55
Incremental Operating Margin (%)	64.09	13.57	10.51	23.03	19.29	71.1	23.38	164.99	- -	-38.14	-43.66	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	7.4	7.01	7.78	16.35	17.84	19.15	11.93	16.17	-7.23	1.36	1.81	0.64	1.29	1.33	-2.22
Net Income to Common Margin (%)	7.35	6.97	7.76	16.34	17.84	19.15	11.93	16.17	-7.23	1.36	1.81	0.64	1.29	1.33	-2.22
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	-0.63	-0.65	-0.37	2.29	3.62	12.51	73.03	101.54	-130.89	1,083.99	842.21	2,919.49	1,622.36	1,610.66	-1,044.22
Sustainable Growth Rate (%)	- -	- -	105.51	122.74	109.37	69.22	7.35	-0.53	-15.71	-11.62	-12.66	-16.1	-18.85	-23.21	-35.85

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	4	3	4	3	3	2
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	3	2	3	2	2	1
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.66	3.65	1.69	-62.48	-2.3	-2.26	-1.18
Net Debt/EBITDA	-0.78	-1.56	-3.39	-2.14	-2.18	-1.95	-3.1	-3.88	19.71	-85.6	-44.84	1,055.56	37.28	11.59	4.01
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.61	5.89	2.02	-15.27	-2.07	-2.03	-1.11
Net Debt/EBIT	-0.91	-1.59	-3.45	-2.15	-2.19	-1.96	-3.14	-3.93	18.26	-138.07	-53.37	258.03	33.62	10.42	3.77
EBITDA to Interest Expense	130.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	129.62	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	111.44	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-15.24	21.72	30.09	50.34	45.76	55.68	56.8	56.9	63.35	63.9	60.48	60.56	60.21	59.38	60.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.08	4.1	3.24	5.96	5.57	4.61	4.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2	3.87	3.08	5.51	5.14	4.26	4.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.32	2.62	1.96	3.61	3.35	2.73	2.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.29	5.82	5.32	8.22	8.33	8.03	8.54
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.11	5.5	5.05	7.6	7.69	7.44	7.87
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.72	3.72	3.22	4.98	5.01	4.77	5.2
Net Debt to Equity	199.88	-220.38	-239.43	-169.44	-184.68	-152.74	-149.32	-147.62	-127.94	-136.44	-140.94	-138.91	-135.04	-41.17	-29.08
Net Debt/Capital (%)	66.65	183.07	171.72	244.02	218.09	289.59	302.78	309.99	540.98	445.53	395.71	452.62	505.47	-61.57	-36.6
EBITDA	2	3	4	21	48	65	44	34	-5	1	2	- -	-2	-1	-2
EBITDA-CapEx	2	3	4	21	47	64	43	34	-5	1	2	- -	-2	-1	-2
Operating Income (Loss)	2	3	4	21	48	64	43	34	-5	1	2	- -	-2	-1	-2

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.23	0.67	1.06	1.83	1.71	2.2	3.23	3.08	3.65	4.29	3.4	3.41	2.81	2.11	2.11
Current Ratio	0.55	0.93	1.25	2.03	1.91	2.47	3.61	3.49	4.12	4.64	3.79	3.79	3.21	2.45	2.5
Quick Ratio	0.25	0.69	1.07	1.84	1.71	2.2	3.23	3.08	3.65	4.29	3.4	3.41	2.81	2.11	2.11
CFO/Avg Current Liab	0.19	0.33	1.07	1.6	1.89	0.9	0.54	0.7	-0.54	0.08	0.04	-0.22	-0.21	-0.17	-0.35
Common Equity/Total Assets	-15.24	21.72	30.09	50.34	45.76	55.68	56.8	56.9	63.35	63.9	60.48	60.56	60.21	59.38	60.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.08	4.1	3.24	5.96	5.57	4.61	4.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2	3.87	3.08	5.51	5.14	4.26	4.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.32	2.62	1.96	3.61	3.35	2.73	2.94
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.29	5.82	5.32	8.22	8.33	8.03	8.54
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.11	5.5	5.05	7.6	7.69	7.44	7.87
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.72	3.72	3.22	4.98	5.01	4.77	5.2
CFO/Total Liabilities	21.11	35.09	77.72	117.34	120.76	81.04	38.6	43.65	-42.91	4.93	2.61	-14.85	-15.56	-14.97	-39.98
CFO/CapEx	209	23.06	50.89	90.3	114.54	58.76	95.7	138.83	-98.61	8.93	4.52	-33.93	-93	-59.07	-88.19
Altman's Z-Score	-17.84	-8.91	-0.29	6.18	7.52	7.04	4.88	5.02	2.38	2.49	2.69	1.98	2.44	2.11	1.62

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	314.77	348.97	410.37	1,033.94	3,230	10,095.72	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	1.16	1.05	0.89	0.35	0.11	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	8.88	9.9	9.31	9.66	7.61	5.06	3.93	3.83	2.17	3.34	3.32	2.59	2.53	2.96	3.96
Days Inventory Outstanding	41.09	36.86	39.19	37.8	47.95	72.17	92.82	95.33	168.57	109.38	109.86	141	144.01	123.51	92.25
Accounts Payable Turnover	3.2	5.27	6.08	10.93	23.87	22.25	18.37	25.51	12.41	22.8	24.59	15.19	12.16	10.78	12.82
Accounts Payable Turnover Days	114.15	69.29	60.01	33.39	15.29	16.4	19.87	14.31	29.41	16.01	14.84	24.03	30.02	33.87	28.46
Cash Conversion Cycle	-71.9	-31.39	-19.93	4.76	32.78	55.8	72.95	81.02	139.16	93.37	95.02	116.97	113.99	89.64	63.79
Inventory to Cash Days	-39.93	-35.81	-38.3	-37.44	-47.84	-72.14	-92.82	-95.33	-168.57	-109.38	-109.86	-141	-144.01	-123.51	-92.25
Inventories	1	1	2	4	10	11	8	12	6	4	5	5	4	3	2
Raw Materials	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1	1	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	11	8	11	6	3	4	4	3	3	2
Other Inventory	1	1	2	4	39	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	7	11	36	143	407	280	172	210	61	57	77	39	67	53	36
- Cash & Cash Equivalents	2	4	15	45	105	126	135	133	96	92	84	70	56	14	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	4	3	4	3	3	2
Enterprise Value	6	7	22	98	302	155	37	78	-31	-32	-3	-26	15	12	9
Total Capital	-1	2	6	26	57	82	91	90	78	72	63	54	45	36	25
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.11	5.5	5.05	7.6	7.69	7.44	7.87
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	-0.1	-0.12	-0.92	-0.16	0.23	0.22	0.23
EV/Sales	0.19	0.2	0.42	0.79	1.14	0.54	0.19	0.4	- -	- -	- -	- -	0.34	0.28	0.22
EV/EBITDA	2.82	2.73	5.09	4.7	6.28	2.4	0.85	2.27	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	3.29	2.78	5.17	4.73	6.31	2.41	0.86	2.3	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	3.32	2.04	3.21	3.71	2.91	1.39	2.61	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	3.18	2	3.18	3.68	2.86	1.38	2.6	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	7	11	36	144	415	283	171	209	58	57	77	39	67	53	36
Diluted Enterprise Value	6	7	22	99	310	158	36	77	-34	-32	-3	-26	14	42	31
EV per Share	0.52	0.65	1.93	7.87	24.89	13.69	3.26	6.83	- -	- -	- -	- -	1.28	1.03	0.76
TTM Sales	31	38	53	125	265	288	198	192	78	62	60	49	44	43	40
TTM EBITDA	2	3	4	21	48	65	44	34	-5	1	2	- -	-2	-1	-2
TTM Operating Income	2	3	4	21	48	64	43	34	-5	1	2	- -	-2	-1	-2
TTM Cash Flow to Firm	- -	2	11	31	81	53	27	30	-19	2	1	-5	-4	-3	-6
TTM Free Cash Flow to Firm	- -	2	11	31	82	54	27	30	-18	2	1	-5	-4	-3	-6

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	4.79	4.91	3.33	4.66	5.06	5.24	6.37	6.99	-3.17	27.14	62.23	-8.32	-15.86	-16.04	-5.99
EV/EBIT	3.29	2.78	5.17	4.73	6.31	2.41	0.86	2.3	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	6	7	22	98	302	155	37	78	-31	-32	-3	-26	15	12	9
Low Price	0.09	0.51	0.77	2.81	10.4	15.9	15.07	14.15	5.06	2.52	4.91	3.27	3.44	4.02	2.4
EV/Sales	0.19	0.2	0.42	0.79	1.14	0.54	0.19	0.4	- -	- -	- -	- -	0.34	0.28	0.22
EV/EBITDA	2.82	2.73	5.09	4.7	6.28	2.4	0.85	2.27	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	3.04	4.23	8.76	6.82	8.73	5.13	7.25	6.73	- -	62.8	68.64	124.51	117.98	92.62	- -
Price/Earnings Average	2.07	5.12	4.4	4.95	7.72	6	11.58	7.69	-18.81	64.75	70.51	206.09	107.52	127.09	-58.33
Price/Earnings High	4.68	7.87	10.27	13.1	14.44	8.23	14.43	9.92	-38.52	104.28	88.85	290.4	141.74	148.35	-78.2
Price/Earnings Low	0.42	2.14	2.11	1.67	2.71	3.29	7.19	5.15	-9.8	31.78	49.86	118.7	69.26	80.59	-31.28
Price/Book Value	-7.89	6.41	6.08	5.41	7.16	3.4	1.9	2.34	0.82	0.84	1.3	0.78	1.62	1.62	1.52
Price/Book Value Average	-5.38	7.76	3.05	3.93	6.33	3.97	3.04	2.67	1.48	0.87	1.33	1.29	1.48	2.22	2.2
Price/Book Value High	-12.14	11.93	7.12	10.4	11.85	5.45	3.79	3.45	3.03	1.4	1.68	1.82	1.95	2.59	2.95
Price/Book Value Low	-1.09	3.24	1.46	1.33	2.22	2.18	1.89	1.79	0.77	0.43	0.94	0.74	0.95	1.41	1.18
Price/Tangible Book Value	-2.73	544.63	8.63	5.8	7.39	3.48	1.94	2.39	0.82	0.84	1.3	0.78	1.62	1.62	1.52
Price/Tangible Book Value Average	-1.86	659.69	4.33	4.21	6.54	4.06	3.1	2.73	1.48	0.87	1.33	1.29	1.48	2.22	2.2
Price/Tangible Book Value High	-4.2	1,013.77	10.11	11.14	12.23	5.57	3.86	3.52	3.03	1.4	1.68	1.82	1.95	2.59	2.95
Price/Tangible Book Value Low	-0.38	275.01	2.08	1.42	2.29	2.22	1.92	1.83	0.77	0.43	0.94	0.74	0.95	1.41	1.18
Price/Sales	0.22	0.29	0.68	1.11	1.56	0.98	0.87	1.09	0.75	0.85	1.24	0.79	1.53	1.23	0.89
Price/Sales Average	0.15	0.36	0.34	0.81	1.38	1.15	1.38	1.24	1.36	0.88	1.27	1.31	1.39	1.69	1.29
Price/Sales High	0.34	0.55	0.8	2.14	2.58	1.58	1.72	1.6	2.78	1.42	1.61	1.85	1.83	1.98	1.73
Price/Sales Low	0.03	0.15	0.16	0.27	0.48	0.63	0.86	0.83	0.71	0.43	0.9	0.76	0.9	1.07	0.69
Price/Cash Flow	4.76	4.99	3.34	4.54	5.07	5.32	6.42	7.04	-3.14	28.08	73.3	-8.03	-15.67	-15.73	-5.92
Price/Cash Flow Average	3.24	6.05	1.68	3.29	4.48	6.21	10.26	8.04	-5.66	28.96	75.3	-13.3	-14.28	-21.59	-8.58
Price/Cash Flow High	7.32	9.29	3.91	8.71	8.39	8.53	12.79	10.36	-11.6	46.64	94.88	-18.73	-18.82	-25.2	-11.5
Price/Cash Flow Low	0.66	2.52	0.8	1.11	1.57	3.4	6.37	5.38	-2.95	14.21	53.24	-7.66	-9.2	-13.69	-4.6
Price/Free Cash Flow Average	3.26	5.95	1.67	3.38	4.47	6.12	10.17	7.99	-5.72	27.99	63.93	-13.77	-14.46	-22.01	-8.68
Price/Free Cash Flow High	7.36	9.14	3.9	8.95	8.36	8.4	12.68	10.3	-11.71	45.07	80.55	-19.41	-19.06	-25.69	-11.63
Price/Free Cash Flow Low	0.66	2.48	0.8	1.14	1.57	3.35	6.32	5.35	-2.98	13.73	45.2	-7.93	-9.31	-13.95	-4.65
EV/Sales Average	0.11	0.26	0.07	0.47	0.96	0.7	0.71	0.56	0.23	- -	- -	- -	0.2	1.45	1.17
EV/Sales High	0.32	0.46	0.53	1.85	2.15	1.13	1.05	0.92	1.73	0.1	0.32	0.53	0.65	1.73	1.62
EV/Sales Low	- -	0.05	- -	- -	0.08	0.19	0.18	0.15	- -	- -	- -	- -	- -	0.82	0.57
EV/EBITDA Average	1.7	3.63	0.88	2.82	5.3	3.13	3.21	3.15	-3.72	-27.6	-0.72	10.48	-5.83	-53.16	-27.49
EV/EBITDA High	4.73	6.4	6.54	11	11.8	5.02	4.77	5.19	-27.56	5.59	10.31	-391.47	-18.82	-63.62	-37.83
EV/EBITDA Low	-0.23	0.63	-1.33	-0.46	0.44	0.83	0.82	0.83	7.19	-55.28	-13.15	427.14	8.69	-30.3	-13.43
EV/EBIT Average	1.98	3.69	0.89	2.83	5.32	3.15	3.25	3.19	-3.44	-44.51	-0.86	2.56	-5.26	-47.8	-25.84
EV/EBIT High	5.52	6.51	6.64	11.06	11.87	5.05	4.83	5.25	-25.53	9.02	12.27	-95.69	-16.97	-57.2	-35.55
EV/EBIT Low	-0.27	0.64	-1.35	-0.46	0.45	0.83	0.83	0.84	6.66	-89.15	-15.65	104.41	7.84	-27.24	-12.62
Last Price	0.65	1.01	3.2	11.45	33.53	24.85	15.19	18.49	5.38	4.98	6.76	3.43	5.86	4.62	3.09
High Price	1	1.88	3.75	21.99	55.45	39.84	30.25	27.23	19.88	8.27	8.75	8	7.04	7.4	6
Enterprise Value Average	4	10	4	59	255	202	140	108	18	-30	-1	-1	9	62	47
Enterprise Value High	10	17	28	230	568	324	208	177	134	6	19	26	28	74	64
Enterprise Value Low	- -	2	-6	-10	21	54	36	28	-35	-60	-25	-28	-13	35	23

Shares Outstanding	11	11	11	13	12	11	11	11	11	11	11	11	12	12	12
Diluted Weighted Avg Shares	11	11	11	13	12	11	11	11	11	11	11	11	11	11	11
Basic Weighted Avg Shares	11	11	11	12	12	11	11	11	11	11	11	11	11	11	11
Revenue per Share	2.91	3.43	4.71	10.27	21.53	25.28	17.56	16.98	7.14	5.84	5.45	4.32	3.84	3.75	3.46
EBITDA per Share	0.19	0.25	0.38	1.72	3.91	5.67	3.87	3.02	-0.45	0.1	0.17	-0.01	-0.13	-0.1	-0.15
Operating Income per Share	0.17	0.24	0.38	1.72	3.89	5.63	3.83	2.98	-0.48	0.06	0.14	-0.02	-0.15	-0.11	-0.16
Basic EPS, GAAP	0.21	0.24	0.37	1.68	3.84	4.84	2.1	2.75	-0.52	0.08	0.1	0.03	0.05	0.05	-0.08
Basic EPS from Cont Ops	0.23	0.24	0.37	1.68	3.84	4.84	2.1	2.75	-0.52	0.08	0.1	0.03	0.05	0.05	-0.08
Diluted EPS, GAAP	0.21	0.23	0.36	1.62	3.82	4.83	2.09	2.74	-0.52	0.07	0.09	0.03	0.05	0.05	-0.08
Diluted EPS from Cont Ops	0.22	0.23	0.36	1.62	3.82	4.83	2.09	2.74	-0.52	0.07	0.09	0.03	0.05	0.05	-0.08
Dividend per Share	- -	- -	- -	0.04	0.14	0.61	1.53	2.79	0.68	0.86	0.83	0.8	0.81	0.8	0.8
Cash Flow per Share	0.14	0.2	0.96	2.52	6.61	4.67	2.36	2.63	-1.71	0.18	0.09	-0.43	-0.37	-0.29	-0.52
Free Cash Flow per Basic Share	0.14	0.19	0.94	2.5	6.55	4.59	2.34	2.61	-1.73	0.16	0.07	-0.44	-0.38	-0.3	-0.53
Cash & Equivalents per Share	0.14	0.37	1.28	3.58	8.64	11.16	11.93	11.66	8.41	8.09	7.34	6.1	4.88	3.82	2.51
Book Value per Share	-0.08	0.16	0.53	2.11	4.68	7.3	7.99	7.9	6.57	5.93	5.21	4.39	3.61	2.86	2.03
Tangible Book Value per Share	-0.24	- -	0.37	1.97	4.53	7.15	7.83	7.74	6.57	5.93	5.21	4.39	3.61	2.86	2.03

Natural Health Trends Corp.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)